13.05.2024 15:41:28 - dpa-AFX: GNW-Adhoc: King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
RIYADH, Saudi Arabia, May 13, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist
Hospital and Research Centre (KFSH&RC) has recently welcomed Dr. Björn Zoéga as
its Deputy CEO, an appointment that underscores its commitment to promoting and
fostering healthcare excellence. Dr. Zoéga, renowned for his extensive
experience in healthcare management and policy, joins a dedicated team as the
hospital continues to drive key strategic initiatives.
KFSH&RC, a leader in medical research and clinical services, continues to
attract global expertise to bolster its vision of healthcare excellence. With
Dr. Zoéga's involvement, the hospital is advancing a digital transformation
strategy designed to improve operational efficiency and enhance patient care.
His expertise in fostering international collaborations, evidenced by his former
role as president of the European University Hospital Alliance (EUHA) and
through initiatives like JOIN4ATMP aimed at advancing access to innovative
therapies, further aligns KFSH&RC's services with global healthcare trends.
Key projects at KFSH&RC include the deployment of advanced digital technologies
to streamline the patient care process, the adoption of innovative care models,
and the upgrading of facility amenities. These strategic efforts aim to improve
access to medical services and facilitate better communication, reflecting
KFSH&RC's dedication to setting new standards in healthcare.
Dr. Zoéga's previous contributions at Karolinska University Hospital, which is
ranked the second best in Europe and seventh globally by Newsweek's 2024 World's
Best Hospitals, where he nurtured a culture of continuous learning and
collaboration among healthcare professionals, align well with KFSH&RC's
objectives. His role in fostering programs like EUCARE and facilitating the
Europe-wide exchange of intensive care nurses during crises has significantly
enhanced staff development and supported his previous hospital's goal of
attracting top talent-a principle mirrored in KFSH&RC's transformation journey.
With Dr. Zoéga contributing to leadership, KFSH&RC is poised to further its role
as a pivotal player in shaping the future of healthcare in Saudi Arabia.
About King Faisal Specialist Hospital and Research Centre:
King Faisal Specialist Hospital & Research Centre stands among the global
leaders in providing specialized healthcare, driving innovation, and serving as
an advanced medical research and education hub. Through strategic partnerships
with prominent local, regional, and international institutions, the hospital is
dedicated to advancing medical technologies and elevating healthcare standards
worldwide.
The hospital has secured its position as the leading brand in the healthcare
sector across the Kingdom and the Middle East, marking its second consecutive
year as the most valuable healthcare brand. It ranks 9th within the Kingdom and
28th in the Middle East. The hospital distinguishes itself as the sole hospital
globally to break into the top 10 brands in its country, as highlighted in two
reports by "Brand Finance" on the 50 most valuable brands in Saudi Arabia and
the 150 most valuable brands in the Middle East in 2024.
Due to the transformation programs and the Kingdom's Vision 2030, launched by
His Royal Highness the Crown Prince and Prime Minister - may God protect him -
to enhance the Kingdom's leadership in the global healthcare sector, KFSH&RC has
emerged as a leading Academic Medical Centre in the Middle East and Africa. It
maintained its 20th rank globally for the second consecutive year in 2024,
according to "Brand Finance." Additionally, it has been ranked among the top
250 hospitals globally in 2024 by the American magazine "Newsweek."
For further information, please contact:
Mr. Essam AlZahrani, Acting Head of Media Affairs, 0555254429
Mr. Abdullah Alown, Media Coordination Officer, 0556294232
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/83d04605-
9a75-41cb-8947-81c858209621
Â